Sign in
Enrolling by invitationNo phase

AI-supported memory training for older adults with mild cognitive impairment

Tests an AI-supported thinking skills program in older adults with mild cognitive impairment.

Key facts

Who runs it
Kaiser Permanente
Where
Pasadena, United StatesSee the site
Trial code
Registry title
AI-Supported Cognitive Rehabilitation for Older Adults With Mild Cognitive Impairment
Status
Enrolling by invitation
People taking part
130 people, planned
Started
16 Mar 2026
Expected to end
31 Dec 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • AI-Supported Cognitive Rehabilitation
Record updated
20 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 65 or older with mild cognitive impairment (MCI), meaning mild problems with memory or thinking. Participants come from an existing Kaiser Permanente Southern California research study.

Age
65 years or older
Sex
All sexes
Disease stage
Diagnosis of mild cognitive impairment (MCI), with a MoCA-BLIND adjusted score of 13-18 (a short test of memory and thinking).
Earlier treatment
People currently getting ongoing behavioral health treatment or psychotherapy from a Kaiser Permanente clinician cannot join.

Main reasons for not taking part

  • Currently getting ongoing behavioral health treatment or psychotherapy from a Kaiser Permanente clinician
  • Bipolar disorder, schizophrenia spectrum disorder, or another serious mental illness that would get in the way of taking part
  • Serious communication problems that would prevent conversation or video/phone sessions
  • Not fluent enough in English for the study tests and sessions
  • No access to, or unable to use, a computer or mobile device with internet

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Age 65 years or older
  • Diagnosis of mild cognitive impairment (MCI)
  • Montreal Cognitive Assessment (MoCA)-BLIND adjusted score (13-18)
  • Able to provide informed consent
  • English fluency sufficient to complete study assessments and participate in intervention sessions
  • Access to and ability to use a computer or mobile device with internet connectivity

Who cannot take part

  • Diagnosis of bipolar disorder, schizophrenia spectrum disorder, or other serious mental illness that would interfere with participation
  • Significant communication impairment that would prevent participation in conversational or telehealth sessions
  • Current receipt of ongoing behavioral health treatment or psychotherapy from a Kaiser Permanente clinician

Where in United States

  • Kaiser Permanente Southern CaliforniaPasadena, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

Mild cognitive impairment (MCI) is associated with increased risk of progression to dementia, highlighting the need for accessible interventions to support cognitive health.

Read full original descriptionShow less

This randomized controlled trial will evaluate the safety and efficacy of a 12-month artificial intelligence (AI)-supported cognitive rehabilitation program for older adults with MCI. Participants will be recruited from an existing research study conducted within Kaiser Permanente Southern California and randomized 1:1 to either (1) AI-supported cognitive rehabilitation or (2) usual care alone.

The intervention combines clinician-delivered telehealth cognitive rehabilitation sessions with daily AI-guided cognitive exercises and education. The primary outcome is change in global cognition at 6 months measured by the Montreal Cognitive Assessment (MoCA)-BLIND. Secondary outcomes at 6 and 12 months include additional measures of cognition, subjective memory, goal attainment, mood, and loneliness. Exploratory outcomes include engagement with the AI intervention and health-related behavioral outcomes derived from electronic health record data.

Participant safety will be monitored throughout the study through adverse event tracking, review of AI interactions for safety concerns, and predefined procedures for responding to psychological or clinical risk.

This study will determine whether integrating AI-guided cognitive exercises with clinician-delivered rehabilitation improves cognitive and related outcomes in older adults with MCI compared to usual care.

The 2 groups in the trial

  • Usual CareNo study treatment, for comparison

    Participants will continue to receive usual health care and services available through their Kaiser Permanente health plan and will complete study assessments at 6 and 12 months.

  • AI-Supported Cognitive RehabilitationTreatment being tested

    Participants will receive a 12-month cognitive rehabilitation program that integrates clinician-delivered telehealth sessions with daily artificial intelligence (AI)-guided cognitive exercises.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Evaluating the Efficacy of AI-Augmented Cognitive Rehabilitation in Mild Cognitive Impairment
Plain-language title
AI-supported memory training for older adults with mild cognitive impairmentGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
20 March 2026